性别与 COPD 患者的精准医学：从性别组学角度考量。
Sex and Gender Omic Biomarkers in Men and Women With COPD: Considerations for Precision Medicine.
机构信息
Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
出版信息
Chest. 2021 Jul;160(1):104-113. doi: 10.1016/j.chest.2021.03.024. Epub 2021 Mar 18.
Abstract
Sex and gender differences in lung health and disease are imperative to consider and study if precision pulmonary medicine is to be achieved. The development of reliable COPD biomarkers has been elusive, and the translation of biomarkers to clinical care has been limited. Useful and effective biomarkers must be developed with attention to clinical heterogeneity of COPD; inherent heterogeneity exists related to grouping women and men together in the studies of COPD. Considering sex and gender differences and influences related to -omics may represent progress in susceptibility, diagnostic, prognostic, and therapeutic biomarker development and clinical innovation to improve the lung health of men and women.
摘要
如果要实现精准肺病医学，就必须考虑和研究肺部健康和疾病中的性别差异。可靠的 COPD 生物标志物的开发一直难以捉摸，生物标志物向临床护理的转化也受到限制。有用且有效的生物标志物必须在关注 COPD 临床异质性的情况下开发；由于在 COPD 的研究中，将女性和男性归为一组，因此存在与分组相关的固有异质性。考虑与组学相关的性别差异和影响因素，可能代表着在易感性、诊断、预后和治疗生物标志物开发以及临床创新方面的进展，从而改善男性和女性的肺部健康。
相似文献
1
Sex and Gender Omic Biomarkers in Men and Women With COPD: Considerations for Precision Medicine.性别与 COPD 患者的精准医学：从性别组学角度考量。
Chest. 2021 Jul;160(1):104-113. doi: 10.1016/j.chest.2021.03.024. Epub 2021 Mar 18.
2
Blood and sputum protein biomarkers for chronic obstructive pulmonary disease (COPD).血液和痰液蛋白生物标志物用于慢性阻塞性肺疾病（COPD）。
Expert Rev Proteomics. 2018 Nov;15(11):923-935. doi: 10.1080/14789450.2018.1539670. Epub 2018 Oct 29.
3
Biomarkers in Chronic Obstructive Pulmonary Disease: The Gateway to Precision Medicine.慢性阻塞性肺疾病的生物标志物：迈向精准医学的大门。
Clin Chest Med. 2020 Sep;41(3):383-394. doi: 10.1016/j.ccm.2020.06.001.
4
Biomarkers for precision medicine in airways disease.气道疾病精准医学的生物标志物
Ann N Y Acad Sci. 2015 Jun;1346(1):18-32. doi: 10.1111/nyas.12809.
5
Biomarker Development in COPD: Moving From P Values to Products to Impact Patient Care.COPD 生物标志物的开发：从 P 值到产品再到影响患者护理。
Chest. 2017 Feb;151(2):455-467. doi: 10.1016/j.chest.2016.09.012. Epub 2016 Sep 29.
6
The Challenges of Precision Medicine in COPD.慢性阻塞性肺疾病精准医学面临的挑战
Mol Diagn Ther. 2017 Aug;21(4):345-355. doi: 10.1007/s40291-017-0266-z.
7
Exploring Molecular Mechanisms and Biomarkers in COPD: An Overview of Current Advancements and Perspectives.探讨 COPD 的分子机制和生物标志物：当前进展和展望概述。
Int J Mol Sci. 2024 Jul 4;25(13):7347. doi: 10.3390/ijms25137347.
8
Chronic obstructive pulmonary disease in women: exploring gender differences.女性慢性阻塞性肺疾病：探索性别差异
Curr Opin Pulm Med. 2004 Mar;10(2):98-103. doi: 10.1097/00063198-200403000-00003.
9
Biomarker Development for Chronic Obstructive Pulmonary Disease. From Discovery to Clinical Implementation.慢性阻塞性肺疾病的生物标志物开发。从发现到临床实施。
Am J Respir Crit Care Med. 2015 Nov 15;192(10):1162-70. doi: 10.1164/rccm.201505-0871PP.
10
The Promise of Observational Studies (ECLIPSE, SPIROMICS, and COPDGene) in Achieving the Goal of Personalized Treatment of Chronic Obstructive Pulmonary Disease.观察性研究（ECLIPSE、SPIROMICS和慢性阻塞性肺疾病基因研究）在实现慢性阻塞性肺疾病个性化治疗目标方面的前景。
Semin Respir Crit Care Med. 2015 Aug;36(4):478-90. doi: 10.1055/s-0035-1555609. Epub 2015 Aug 3.
引用本文的文献
1
Global burden of disease study on COPD in the older adult: comprehensive analysis of environmental factors and interaction effects.老年人慢性阻塞性肺疾病的全球疾病负担研究：环境因素及交互作用的综合分析
Front Public Health. 2025 May 30;13:1597793. doi: 10.3389/fpubh.2025.1597793. eCollection 2025.
2
Association Between Physical Activity, Sedentary Behavior and Sleep Disorders in Chronic Obstructive Pulmonary Disease Patients: A Cross-Sectional Study.慢性阻塞性肺疾病患者身体活动、久坐行为与睡眠障碍之间的关联：一项横断面研究
Int J Chron Obstruct Pulmon Dis. 2025 Apr 22;20:1175-1187. doi: 10.2147/COPD.S487616. eCollection 2025.
3
Sex-specific spirometry effects of adult COPD polygenic score in children with asthma.成人慢性阻塞性肺疾病多基因评分对哮喘儿童的性别特异性肺量计测定影响
Sci Rep. 2025 Apr 2;15(1):11258. doi: 10.1038/s41598-025-94804-6.
4
Sex differences in asthma: omics evidence and future directions.哮喘中的性别差异：组学证据与未来方向。
Front Genet. 2025 Mar 5;16:1560276. doi: 10.3389/fgene.2025.1560276. eCollection 2025.
5
Pulmonary Immunocompromise in Human Immunodeficiency Virus Disease.人类免疫缺陷病毒病中的肺部免疫功能低下
Clin Chest Med. 2025 Mar;46(1):185-201. doi: 10.1016/j.ccm.2024.10.014. Epub 2024 Nov 28.
6
Sex-biased Regulation of Extracellular Matrix Genes in COPD.慢性阻塞性肺疾病中细胞外基质基因的性别差异调控
Am J Respir Cell Mol Biol. 2024 Aug 5;72(1):72-81. doi: 10.1165/rcmb.2024-0226OC.
7
Association between nutrition-related indicators with the risk of chronic obstructive pulmonary disease and all-cause mortality in the elderly population: evidence from NHANES.老年人群中营养相关指标与慢性阻塞性肺疾病风险及全因死亡率之间的关联：来自美国国家健康与营养检查调查（NHANES）的证据
Front Nutr. 2024 Jul 16;11:1380791. doi: 10.3389/fnut.2024.1380791. eCollection 2024.
8
Early Diagnosis of High-Risk Chronic Obstructive Pulmonary Disease Based on Quantitative High-Resolution Computed Tomography Measurements.基于定量高分辨率 CT 测量的高危慢性阻塞性肺疾病的早期诊断。
Int J Chron Obstruct Pulmon Dis. 2023 Dec 27;18:3099-3114. doi: 10.2147/COPD.S436803. eCollection 2023.
9
Machine Learning-Based Proteomics Reveals Ferroptosis in COPD Patient-Derived Airway Epithelial Cells Upon Smoking Exposure.基于机器学习的蛋白质组学揭示了吸烟暴露后 COPD 患者气道上皮细胞中的铁死亡。
J Korean Med Sci. 2023 Jul 24;38(29):e220. doi: 10.3346/jkms.2023.38.e220.
10
Asthma Exacerbations: The Genes Behind the Scenes.哮喘恶化：幕后的基因。
J Investig Allergol Clin Immunol. 2023 Apr 18;33(2):76-94. doi: 10.18176/jiaci.0878. Epub 2022 Nov 24.
本文引用的文献
1
Whole genome sequence analysis of pulmonary function and COPD in 19,996 multi-ethnic participants.对 19996 名多民族参与者的肺功能和 COPD 的全基因组序列分析。
Nat Commun. 2020 Oct 14;11(1):5182. doi: 10.1038/s41467-020-18334-7.
2
Sex-specific associations with DNA methylation in lung tissue demonstrate smoking interactions.肺组织中 DNA 甲基化的性别特异性关联表明吸烟存在交互作用。
Epigenetics. 2021 Jun;16(6):692-703. doi: 10.1080/15592294.2020.1819662. Epub 2020 Sep 22.
3
Sex-Specific Associations of Cardiovascular Risk Factors and Biomarkers With Incident Heart Failure.心血管危险因素和生物标志物与心力衰竭事件的性别特异性关联。
J Am Coll Cardiol. 2020 Sep 22;76(12):1455-1465. doi: 10.1016/j.jacc.2020.07.044.
4
Sex differences between women and men with COPD: A new analysis of the 3CIA study.COPD 患者中女性与男性的性别差异：3CIA 研究的新分析。
Respir Med. 2020 Sep;171:106105. doi: 10.1016/j.rmed.2020.106105. Epub 2020 Aug 13.
5
Sex and gender: modifiers of health, disease, and medicine.性别与健康、疾病和医学。
Lancet. 2020 Aug 22;396(10250):565-582. doi: 10.1016/S0140-6736(20)31561-0.
6
Biomarkers in Chronic Obstructive Pulmonary Disease: The Gateway to Precision Medicine.慢性阻塞性肺疾病的生物标志物：迈向精准医学的大门。
Clin Chest Med. 2020 Sep;41(3):383-394. doi: 10.1016/j.ccm.2020.06.001.
7
Combined Utility of 25 Disease and Risk Factor Polygenic Risk Scores for Stratifying Risk of All-Cause Mortality.25 种疾病和风险因素多基因风险评分联合用于分层全因死亡率风险。
Am J Hum Genet. 2020 Sep 3;107(3):418-431. doi: 10.1016/j.ajhg.2020.07.002. Epub 2020 Aug 5.
8
Chronic obstructive pulmonary disease and related phenotypes: polygenic risk scores in population-based and case-control cohorts.慢性阻塞性肺疾病及相关表型：基于人群和病例对照队列的多基因风险评分。
Lancet Respir Med. 2020 Jul;8(7):696-708. doi: 10.1016/S2213-2600(20)30101-6.
9
Sex Differences in Gene Expression and Regulatory Networks across 29 Human Tissues.29 个人体组织中的基因表达和调控网络的性别差异。
Cell Rep. 2020 Jun 23;31(12):107795. doi: 10.1016/j.celrep.2020.107795.
10
Sex and gender differences and biases in artificial intelligence for biomedicine and healthcare.生物医学与医疗保健领域人工智能中的性别差异与偏见
NPJ Digit Med. 2020 Jun 1;3:81. doi: 10.1038/s41746-020-0288-5. eCollection 2020.
Zotero 插件